KBP-042

· KeyBioscience AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KBP-042, covering 2018-09-11 to 2018-09-11. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes [Phase 2]